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Recurrent pericarditis occurs in 15% to 30% of patients with idio-pathic acute pericarditis (1,2), and may be associated with pleural 
effusion. The pathogenesis of relapses is still unclear, and recurrences 
may persist over several years.
Treatment is often challenging because of frequent relapses of chest 
pain and poor efficacy of anti-inflammatory agents. A familial form of 
recurrent pericarditis has been reported by some studies. We describe 
three related female patients with recurrent pericarditis associated 
with pericardial and pleural effusions.
Patient 1
Patient 1 was admitted to hospital in 1979, with acute dyspnea, fever 
and cough; she was 18 years of age. Her chest x-ray revealed pleural 
and pericardial effusions, and she underwent a thoracentesis and treat-
ment with nonsteroidal anti-inflammatory drugs. After a few months, 
she suffered a relapse with fever and chest pain; a large pericardial effu-
sion with echocardiographic signs of cardiac tamponade were present, 
and pericardiocentesis was performed with aspiration of 1500 mL of 
pericardial fluid, followed by intracavitary administration of anti-
inflammatory agents (methylprednisolone 40 mg). Cytological and 
microbiological examination and cultures of the pericardial fluid were 
negative, and the patient’s protein level was 4.5 g/100 mL. Anti-
tuberculosis treatment was started empirically.
In early 1980, a second relapse occurred with fever, chest pain and 
a large pericardial effusion. Serological markers of autoimmune dis-
eases and streptococcal infection were repeatedly negative. In June 
1980, the patient was admitted to hospital for persistent pericardial 
effusion; all of her laboratory test results were within normal limits.
In August 1980, she suffered from a persistent cough; the pericar-
dial effusion was still present, although it was slightly reduced com-
pared with previous echocardiographic examinations.
In December 1980, the patient underwent pericardiocentesis of 10 mL 
of pericardial fluid; the only anomalous laboratory findings were elevated 
levels of C-reactive protein (CRP) and erythrocyte sedimentation rate 
(ESR). Treatment with acetylsalicylic acid 2400 mg/day was initiated.
In 1981, the patient underwent partial pericardiectomy due to 
persistence of a large pericardial effusion and intermittent fever associ-
ated with elevated ESR and CRP levels, despite continuous treatment 
with antiphlogistic and antituberculosis agents; the histological exam-
ination of the pericardium revealed nonspecific signs of inflammation. 
No further relapses occurred thereafter.
Patient 2 (niece of Patients 1 and 3)
In 1997, patient 2 suffered a chest trauma. She was first admitted to hos-
pital in April 1999 at 18 years of age, due to a chance finding of an 
enlarged cardiac silhouette. An echocardiogram revealed a large pericar-
dial effusion without signs of cardiac tamponade. Serological markers of 
autoimmune diseases and of streptococcal infection were negative; ESR 
and CRP levels were normal. Chest computed tomography and a tine test 
were also negative. Treatment with prednisone 50 mg daily was initiated.
Two months later, her chest pain, fever, pericardial and bilateral 
pleural effusions resumed after reduction of the antiphlogistic drugs, and 
the patient’s ESR and CRP levels were elevated. She underwent pericar-
diocentesis with drainage of 1100 mL of pericardial fluid; cytological and 
microbiological examinations of the fluid were negative. Antituberculosis 
chemotherapy was initiated without significant benefit, and was discon-
tinued in March 2000. Episodes of chest pain and fever continued until 
2005, when a prolonged course of colchicine treatment was initiated 
(discontinued in 2008). No further relapses were recorded in follow-up 
visits. Her ocular pressure was normal.
Patient 3 (sister of Patient 1)
The patient was first admitted to hospital in 2006 at 35 years of age for 
cardiac tamponade after experiencing a few days of fever, sore throat and 
chest pain. The patient underwent emergency pericardiocentesis, and 
2000 mL of pericardial exudate was aspirated. Despite treatment with 
nonsteroidal anti-inflammatory agents and antibiotic therapy, a large 
pericardial effusion recurred after two days. Pericardiocentesis was repeated 
with aspiration of 1100 mL of pericardial fluid; continuous 48 h pericardial 
drainage was performed. Thoracentesis and evacuation of 650 mL of 
pleural exudate was also performed. ESR and CRP levels were elevated; 
serological evaluation and cytological examination of evacuated fluids 
were normal. A culture of pericardial fluid was positive for Staphylococcus 
epidermidis (one of three samples); cultures of pleural effusion and blood 
were negative for tuberculosis. Systemic treatment with steroidal anti-
inflammatory agents (prednisone 50 mg/day) and antibiotics was 
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Three cases of recurrent pleuropericarditis were observed within the same 
family – in two sisters and their niece, who were 18, 35 and 18 years of age, 
respectively. One patient was treated with pericardiectomy, and the other 
two were treated with colchicine. Mutations associated with autoinflam-
matory diseases (tumour necrosis factor receptor-associated periodic syn-
drome and familial Mediterranean fever) were absent; the condition was 
found to be sex linked.
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initiated. Colchicine was added to the treatment regimen for relapse of 
pericardial-pleural effusions. Persistence of mild-to-moderate pleuro-
pericardial effusion was recorded during follow-up. Steroidal treatment 
was discontinued in March 2006, while treatment with colchicine was 
discontinued in February 2009, on complete resolution of residual peri-
cardial effusion detected by echocardiography. The patient remains 
recurrence free. In this case as well, intraocular pressure was normal. 
The three patients are linked by close kinship: patients 1 and 3 are sis-
ters, and aunts of patient 2. Table 1 describes the clinical characteristics 
of the three patients.
After providing written consent for genetic testing, all three patients 
were tested for mutations in the TNFRSF1A gene (Exons 2-4,6), 
which is responsible for autosomal dominant tumour necrosis factor 
receptor-associated periodic syndrome (TRAPS), and in the MEFV 
gene (Exons 2,3,10), which is responsible for autosomal recessive fam-
ilial Mediterranean fever (FMF), where the majority of known muta-
tions are found (3). No mutations were found in patient 1 or in 
patient 3, whereas patient 2 harboured a heterozygous K695R muta-
tion in the MEFV gene (exon 10).
discUssion
Recurrent pericarditis is most frequently of idiopathic, postpericardiotomic 
or postinfarction origin (4). The present article reports on a severe form of 
recurrent pericarditis, with a possible genetic x-linked association.
We recorded many relapses of exudative pericarditis in each of our 
patients that were frequently associated with pleural effusions. A broad 
spectrum of anti-inflammatory agents proved ineffective in preventing 
recurrences and treating acute episodes, with the exception of colchi-
cine, which was fairly effective in cases 2 and 3; case 1 required 
pericardiectomy.
Common causes of pericarditis were excluded in each patient through 
thorough clinical, serological and pathological evaluation. During acute 
phases, elevated systemic inflammation markers (eg, ESR and CRP levels) 
and fever were invariably present, while the association with pleural effu-
sion was almost always present. Searches for autoimmune disease markers 
were always negative. Pleural and pericardial fluids drained from each 
patient in different phases of their history showed high protein concentra-
tions (exudate); cytological and microbiological evaluations were nega-
tive for cancer or infections. Intracavitary and systemic treatment with 
corticosteroids had low efficacy when administered alone, while associa-
tion with systemic colchicine was effective.
Some familial clustering of recurrent pericarditis was found by 
Genecin (5) who reported the presence of effusive pericarditis in 
two siblings. In one sibling, the evaluation of pericardial fluid revealed 
a typical macroscopical aspect called ‘gold paint’, with a high level of 
cholesterol. This finding was not present in our patients.
A family cluster of pericarditis was reported by De Line and Cable 
(6). Recurrent pericarditis with pericardial effusion was diagnosed in 
three male and two female patients, and an idiopathic etiology was 
assigned to each case; no other serositis was reported. Two of the patients 
developed pericardial constriction and underwent pericardiectomy or 
creation of a pericardial window. Erdol et al (7) described a family in 
which three female members had idiopathic chronic pericarditis that 
was unresponsive to anti-inflammatory agents and associated with glau-
coma. The authors suggested a sex-linked inheritance. In a series of 
60 Caucasian patients affected by recurrent idiopathic pericarditis, 
Brucato and Brambilla (8) identified six patients who had at least 
one relative with a confirmed diagnosis of acute pericarditis. Three of 
six patients had recurrent pericarditis, and these data suggest a genetic 
predisposition in some cases of recurrent pericarditis.
Because recurrent pericarditis is characterized by periodic recur-
rences alternating with symptom-free intervals during which acute-
phase reactants normalize, increasing attention is currently being 
devoted to autoinflammatory disorders – a group of genetic diseases 
caused by a primary dysfunction of the innate immune system and char-
acterized by spontaneously relapsing and remitting bouts of systemic 
inflammation (9).
Among autoinflammatory disorders, recurrent pericarditis, usually 
in the form of polyserositis, is a common feature both of TRAPS (10), 
caused by mutations in the TNFRSF1A gene encoding the 55 kD 
receptor for tumour necrosis factor-alpha, and of FMF, caused by muta-
tions in the MEFV gene, encoding for the pyrin protein (11,12).
Autoinflammatory disorders may be responsible for isolated (13-15) 
and familial cases of recurrent pericarditis (16). We investigated the 
presence of FMF in three series of Italian patients with recurrent pericar-
ditis; mutations in the MEFV gene were searched in 23, 61 and 
30 patients, respectively; however, no patients with FMF were discov-
ered (13,17,18).
On the other hand, we recently reported patients with mutations 
in the TNFRSF1A gene, presenting with recurrent pericarditis as the 
sole clinical manifestation (13,14,16).
In addition, we proposed criteria (positive family history and poor 
response to colchicine) for identifying, among patients with recurrent 
pericarditis, those who should undergo testing for genetic mutations of 
the TNFRSF1A gene that would reveal TRAPS (13,16).
In contrast, despite the familial clustering of pericarditis, none of 
the three patients who were reported in the present study harboured 
mutations in the TNFRSF1A gene. Additionally, the fairly positive 
response to colchicine also suggested a possible association with a 
mutation in the MEFV gene; however, on investigation, none of these 
patients had FMF.
figure 1) Family pedigree. Affected individuals are numbered for each level 
with birth year indicated
Table 1
Clinical characteristics of patients and treatments
Patient 1 Patient 2 Patient 3
Age of first hospitalization 18 years 18 years 35 years
Kinship Aunt of patient 2 







Pleural effusion Yes Yes Yes
Pericardial effusion Yes Yes Yes
Number of relapses of  
pericardial effusion
4 2 2
Pericardiocentesis Yes Yes Yes
Pericardiectomy Yes No No
Anti-inflammatory therapy Yes Yes Yes
Antituberculosis therapy Yes Yes Yes
Colchicine therapy No Yes Yes
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In the family tree of our cases (Figure 1), all of the affected subjects 
were female (II 1, II 2 and III 7); thus suggesting an x-linked dominant 
inheritance. Such an event is rare, as reported by Erdol et al (7). On the 
other hand, disease-free male subjects in the family tree were too young 
to exclude a predisposition to develop symptoms later in life.
Alternative inheritance patterns are plausible, such as an auto-
somal dominant incomplete penetrance mechanism, in which female 
patients are the casualty (in the second generation, all five subjects 
were female). Another alternative is poligenic inheritance (6), in 
which several cases of a noninfrequent disease are recorded in subse-
quent generations of the same family, as occurs in bilateral congenital 
clubfoot syndrome (XXX).
In our cluster of patients, genetic transmission of the disease is 
plausible for three main reasons: severity of the disease, occurrence in 
two different generations and prevalence in female subjects.
Given that the three female patients presented in our report had 
recurrent pericarditis that was idiopathic in origin, because etiological 
evaluations were invariably negative, an x-linked dominant genetic 
predisposition to inflammatory pericarditis cannot be excluded.
sUMMary
We report a cluster of familial recurrent pleuropericarditis, not associ-
ated with the mutations related to known autoinflammatory condi-
tions, where an x-linked transmission cannot be excluded.
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